ArticleBriefings in bioinformatics2025
VF-Fuse: a dual-path feature fusion and iterative update architecture for virulence factor prediction.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate prediction of bacterial virulence factors (VFs) is crucial for combating infectious diseases, yet traditional methods often fail to capture their complex sequence properties. We address this challenge by leveraging deep, context-aware representations from large-scale protein language models (PLMs). Our framework begins with a systematic engineering of features from ESM-2 and ProtT5, which confirmed their complementary nature but also revealed that simple concatenation is a suboptimal fusion strategy due to a "feature overshadowing" effect. To overcome this, we developed two novel architectures: VF-Iter, for robust feature enhancement via iterative low-rank updates, and the Dual-Path Feature Fusion (DPF) network, for intelligently integrating the complementary embeddings. The construction of our final model, VF-Fuse, involved a two-stage process. First, we selected four powerful and diverse base models representing our distinct feature strategies (ESM-2 only, ProtT5 only, simple concatenation, and DPF). Second, we empirically determined the best method for combining their predictions by benchmarking 15 ensemble techniques, from which Majority Voting emerged as the superior choice. On the independent test set, VF-Fuse establishes a new state of the art, achieving a superior F1-Score of 87.15% and a Matthews Correlation Coefficient of 73.61%. This F1-Score marks a significant 3.3% improvement over the previous best method, driven by an excellent balance between a high Sensitivity of 90.1% and a strong Specificity of 83.33%. Crucially, in-depth interpretability analyses validated our architectural design, demonstrating how the DPF model learns to intelligently route complementary features to specialized pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.